Julia G. Levy
Vorsitzender bei Valocor Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Julia G. Levy
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.
27
| Extinct | Miscellaneous Commercial Services | 27 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada.
21
| Extinct | Pharmaceuticals: Major | 21 |
| Extinct | Pharmaceuticals: Major | 15 | |
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada.
8
| Holding Company | Biotechnology | 8 |
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada.
7
| Holding Company | Biotechnology | 7 |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada.
5
| Holding Company | Biotechnology | 5 |
Valocor Therapeutics, Inc.
 Valocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Valocor Therapeutics is a clinical-stage, privately-held company dedicated to developing innovative treatments for major unmet needs in dermatology. The company's portfolio of dermatology therapeutics includes Lemuteporfin, a potent and selective topical photodynamic therapy for moderate to severe acne and a portfolio of novel, topical small molecule therapeutics targeting acne, sebaceous gland hyperactivity, skin pigmentation disorders and inflammatory skin diseases. Valocor Therapeutics is headquartered in Vancouver, British Columbia. Although many common yet serious skin conditions have unsatisfactory treatment options, dermatology has in recent years attracted limited research resources and investment. As a result, a sparse pipeline and a lack of true scientific innovation have been the dominant themes of this field for the last twenty years. During this same period, technological advances have produced new research techniques that have greatly expanded its ability to study disease processes and establish new effective therapeutic strategies. Much of this innovative research has been applied to the fields such as oncology, autoimmunity, and ocular diseases. Valocor is applying current biotechnology techniques to develop breakthrough therapies for major dermatological diseases, where prevalent conditions, minimal competition and important medical needs exist.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Pender Private Investments Inc
 Pender Private Investments Inc Investment ManagersFinance Working Opportunity Fund (EVCC) Ltd seeks investment opportunities in companies located in British Columbia (Canada). The fund targets companies operating in the fields of information technology, life sciences, and clean technologies. It provides financing for early and later stage capital requirements.
1
| Family of Fds (VC/Pvt EQ) | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Julia G. Levy
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of British Columbia | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Undergraduate Degree Masters Business Admin Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director of Finance/CFO Corporate Secretary Chairman Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer General Counsel | |
| University of Toronto | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Doctorate Degree Doctorate Degree Graduate Degree | |
| Simon Fraser University | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Chairman Director/Board Member Chief Executive Officer Director/Board Member Founder | |
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer Director of Finance/CFO General Counsel | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| McMaster University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Chief Executive Officer Director/Board Member Corporate Officer/Principal Human Resources Officer | |
Michael Smith Foundation for Health Research
 Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member Chairman | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Human Resources Officer | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman Chairman Director/Board Member Director/Board Member | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| GALENICA AG | Medical Distributors | Chairman Director of Finance/CFO Chairman | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| GLOBAL GAMING TECHNOLOGIES CORP. | Financial Conglomerates | Director/Board Member President Director of Finance/CFO | |
| Kellogg School of Management | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Genome British Columbia
 Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Law Society of British Columbia
 Law Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Law Society of British Columbia provides legal services. The firm protects the public interest in the administration of justice by setting and enforcing standards of professional conduct for lawyers. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BC Biotech
 BC Biotech Investment Trusts/Mutual FundsMiscellaneous BC Biotech is a Canadian biotechnology company that works in the field of applied biology, using engineering, medicine, and technology in conjunction with living organisms and bioprocesses. BC Biotech also provides information on how to study biotechnology in school and which institutions are known for their program. The non-profit company is based in Vancouver, Canada. The company aims to promote businesses in the biotechnology industry and inform people about the science behind it. | Investment Trusts/Mutual Funds | Director/Board Member Chairman Chairman | |
Canadian Partnership Against Cancer Corp.
 Canadian Partnership Against Cancer Corp. Miscellaneous Commercial ServicesCommercial Services Canadian Partnership Against Cancer initiates and implements cancer control programs. It offers prevention and screening; diagnosis and clinical care; person-centered perspective; research; system performance; knowledge management; and public engagement and outreach. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Chairman Chairman | |
| BC Technology Industry Association | Director/Board Member Director/Board Member | ||
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Innovate BC
 Innovate BC Miscellaneous Commercial ServicesCommercial Services Innovate BC develops entrepreneurial talent and supports commercializing technology. The firm focuses on competitively positioning British Columbia in today's global knowledge economy in order to provide significant employment opportunities and a high standard of living for British Columbians. The company was founded in 1978 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
Order of Canada
 Order of Canada Miscellaneous Commercial ServicesCommercial Services Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Concordia University | College/University | Undergraduate Degree Undergraduate Degree | |
| NORDION INC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GrowthWorks Capital Ltd.
 GrowthWorks Capital Ltd. Investment ManagersFinance GrowthWorks Capital Ltd. (GrowthWorks) is a venture capital firm founded in 1992 by David Levi. The firm is headquartered in Vancouver, Columbia with additionaal offices in Saskatchewan, Manitoba, New Brunswick, Newfoundland, Nova Scotia, and Ontario. | Investment Managers | Private Equity Investor Private Equity Investor | |
BioStorage Technologies, Inc.
 BioStorage Technologies, Inc. Drugstore ChainsRetail Trade BioStorage Technologies, Inc. provides biological sample storage, DNA storage, shipping, tracking and reporting services. The firm provides sample management consulting, supply chain, logistics, relocation, preparation, storage, and business continuity consulting and disaster recovery services. It offers onsite, offsite and hybrid sample outsourcing models for the management of sample assets. The company was founded by F. John Mills and Oscar Moralez in 2002 and is headquartered in Indianapolis, IN. | Drugstore Chains | Director/Board Member Director/Board Member | |
| University of London | College/University | Doctorate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree |
Statistik
International
| Kanada | 40 |
| Vereinigte Staaten | 8 |
| Schweiz | 3 |
| Israel | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 4 |
| Miscellaneous | 3 |
Operativ
| Director/Board Member | 522 |
| Corporate Officer/Principal | 197 |
| Chairman | 117 |
| Independent Dir/Board Member | 116 |
| Chief Executive Officer | 100 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Alan C. Mendelson | 45 |
| Alan Torrie | 34 |
| Lorne Gertner | 32 |
| Magda Marquet | 30 |
| Ken Galbraith | 30 |
| Ron Hunt | 29 |
| Michael Hayden | 27 |
| R. MacKay-Dunn | 26 |
| Richard Glickman | 26 |
| Peter Alexander Crossgrove | 26 |
| Paul Hastings | 25 |
| George Milne | 24 |
| Kirk Calhoun | 23 |
| Bill Hunter | 22 |
| Anthony Giovinazzo | 22 |
- Börse
- Insiders
- Julia G. Levy
- Unternehmensverbindungen